Identification of minimal hepatic encephalopathy in patients with cirrhosis based on white matter imaging and Bayesian data mining
- PMID: 25500314
- PMCID: PMC8013047
- DOI: 10.3174/ajnr.A4146
Identification of minimal hepatic encephalopathy in patients with cirrhosis based on white matter imaging and Bayesian data mining
Abstract
Background and purpose: White matter abnormalities have been demonstrated to play an important role in minimal hepatic encephalopathy. In this study, we aimed to evaluate whether WM diffusion tensor imaging can be used to identify minimal hepatic encephalopathy among patients with cirrhosis.
Materials and methods: Our study included 65 patients with cirrhosis with covert hepatic encephalopathy (29 with minimal hepatic encephalopathy and 36 without hepatic encephalopathy). Participants underwent DTI, from which we generated mean diffusivity and fractional anisotropy maps. We used a Bayesian machine-learning technique, called Graphical-Model-based Multivariate Analysis, to determine WM regions that characterize group differences. To further test the clinical significance of these potential biomarkers, we performed Cox regression analysis to assess the potential of these WM regions in predicting survival.
Results: In mean diffusivity or fractional anisotropy maps, 2 spatially distributed WM regions (predominantly located in the bilateral frontal lobes, corpus callosum, and parietal lobes) were consistently identified as differentiating minimal hepatic encephalopathy from no hepatic encephalopathy and yielded 75.4%-81.5% and 83.1%-92.3% classification accuracy, respectively. We were able to follow 55 of 65 patients (median = 18 months), and 15 of these patients eventually died of liver-related causes. Survival analysis indicated that mean diffusivity and fractional anisotropy values in WM regions were predictive of survival, in addition to the Child-Pugh score.
Conclusions: Our findings indicate that WM DTI can provide useful biomarkers differentiating minimal hepatic encephalopathy from no hepatic encephalopathy, which would be helpful for minimal hepatic encephalopathy detection and subsequent treatment.
© 2015 by American Journal of Neuroradiology.
Figures
References
-
- Ferenci P, Lockwood A, Mullen K, et al. . Hepatic encephalopathy: definition, nomenclature, diagnosis, and quantification—final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 2002;35:716–21 - PubMed
-
- Stewart CA, Malinchoc M, Kim WR, et al. . Hepatic encephalopathy as a predictor of survival in patients with end-stage liver disease. Liver Transpl 2007;13:1366–71 - PubMed
-
- Bajaj JS, Wade JB, Sanyal AJ. Spectrum of neurocognitive impairment in cirrhosis: implications for the assessment of hepatic encephalopathy. Hepatology 2009;50:2014–21 - PubMed
-
- Groeneweg M, Quero JC, De Bruijn I, et al. . Subclinical hepatic encephalopathy impairs daily functioning. Hepatology 1998;28:45–49 - PubMed
-
- Romero-Gómez M, Boza F, Garcia-Valdecasas MS, et al. . Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy. Am J Gastroenterol 2001;96:2718–23 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources